Novartis Cancer Trials Over Time

Brendan Kelleher —  April 3, 2013 — 1 Comment
Trend of Novartis Cancer Trials

Trend of Novartis Cancer Trials

This week’s featured datacard is from our friend (and thoughtful beta user) Moe Alsumidaie from Annex Clinical.  The datacard trends Novartis’ cancer (ICD-9 140-239) trials over time by trial start date. Trials have steadily increased over time and already have 10 started or planned for 2013.  (As an aside, Moe runs a thoughtful on LinkedIn for those interested in the clinical space: Breakthrough Solutions in Clinical Trials and Healthcare.)

Advertisements

One response to Novartis Cancer Trials Over Time

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s